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  Thirty－one patients with pedunculated， non－infiltrative tumor of the bldder was continu－
ously administered SLA． ，’b?狽＝|glucuronidase inhibitor， after surgery． The recurrence rate of
the SLA－treatment group was ’12．9fe15 within six months， 38．1％． within one year， 50．0％
within two year， and 81．8 60 within three year． This result was compared with the recurrence
rate of the non－prevention group in the preceding paper．
  Within the first two years， the recurrence rate was always lower in the SLA一．crroup
though not so significantly by statistical analysis．
  Some cases obviously showed the preventive effect of SLA against recurrence of tumor
of the bladder．
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Table 2 Recurren6es of the bladder caricer
      after administration of SLA．
                       F ： fulguration
Table ’R Recurrences of the bladder caricer
      without treatment aft’er ・ehe first
      operqtion． ・









































Cases used SLA after the first
 treatment



























使 用 症 例
 3ユ症例（Table 2）のうちの代表的なものについて，
その経過を簡単にしるす．
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包装 2ml 10管・100管，5ml 5管・50管，20ml 5管。30管
     健保薬価 2ml 26円，5血140円，20ml 141円
    レ適応症 感冒，気管支炎，喘息，肝炎，肝
         障害，腎炎，ネフローゼ，血管性
         紫斑病，白血球減少症，丁丁中毒，
         湿疹，皮膚炎，蔀麻疹，小児スト
ロフルス，神経痛，リウマチ，腰・
背痛，妊娠中毒，特発性腎出血，
急性出血性膀胱炎，中耳炎，副鼻腔
炎，口内炎，ブリクチン，．結膜炎，
角膜炎，薬物副作用，薬物過敏症
など
ミノファー・ゲン製薬 東京都新宿区新宿3－31
